Findings suggest a significant association between GDF15 and HT, though further research is required to establish definitive causality and reflect the limitations of the NaI-induced model.
Abstract
Introduction Hashimoto's thyroiditis (HT) is a prevalent autoimmune thyroid disorder, typically triggers localized thyroid inflammation and systemic dyslipidemia, and progression to hypothyroidism. While growth differentiation factor 15 (GDF15) is recognized for its role in lipid metabolism and inflammatory diseases, its specific involvement in HT remains elusive. Methods We conducted plasma metabolomic profiling in HT patients and matched healthy controls to identify altered metabolic pathways. Correlation analysis was performed between serum GDF15 and clinical indicators. In vitro thyroid follicular cell models and NaI-induced in vivo thyroid inflammatory models were applied with GDF15 overexpression, knockdown, recombinant protein and siRNA treatment to explore the functional role of GDF15. Results Plasma metabolomic profiling in HT patients revealed that differentially expressed metabolites are predominantly enriched in lipid metabolism pathways. GDF15 expression was increased by 1.98-fold in HT serum compared to controls (p < 0.001), and serum GDF15 levels were negatively correlated with thyroid-stimulating hormone (TSH, R = −0.4943, p = 0.0040), aspartate aminotransferase (AST, R = −0.4506, p = 0.0238) and ultrasound attenuation parameter (UAP, R = −0.4894, p = 0.0071) in HT patients. Functional assays demonstrated that GDF15 overexpression tends to attenuate NaI-induced thyroid and systemic inflammation, relatively improving lipid profiles and reduces hepatic lipid deposition; however, GDF15 knockdown appeared to exacerbate these pathologies. Furthermore, recombinant GDF15 protein mitigates NaI-induced inflammatory responses in thyroid follicular cells, whereas GDF15 siRNA intensifies the inflammation. Discussion Given the limitations of the NaI-induced model and the lack of thyroid-specific genetic manipulation, these findings suggest a significant association between GDF15 and HT, though further research is required to establish definitive causality.
A testable positive-feedback perspective in which thyrocyte ERS injury and immune effector amplification may mutually reinforce one another is proposed, in which thyrocyte ERS injury and immune effector amplification may mutually reinforce one another.
X. Si, Zhi-Xun Guo, Ge-Na Jiao et al.· Frontiers in Immunology· 0 citations
This study provides a multimodal characterization of necroptosis in HT, showing that the inflammatory immune microenvironment is associated with TFC loss and activation of an RIPK3-MLKL-predominant necroptosis-related program, without detectable upregulation of total or phosphorylated RIPK1.
Dong-Yu Yang, Cihang Lu, Wei-Ping Teng et al.· Frontiers in Immunology· 0 citations
Routine systemic inflammatory markers do not meaningfully distinguish autoimmune from non-autoimmune thyroid disease phenotypes, and these findings support the concept that autoimmune thyroid diseases predominantly reflect localized rather than systemic inflammatory activation.
S. Akan, Yavuz Selim Sılay· Family Practice and Palliati...· 0 citations
Compared with NLR and SII, the monocyte-containing indices MLR, SIRI, and PIV showed clearer differences across thyroid functional states in Graves’ disease and may provide complementary inflammation-related information.
Wen-Jie Sun, Hui Chen· Frontiers in Endocrinology· 0 citations
Findings position exosomes as central contributors to HT pathogenesis and highlight their value as emerging diagnostic biomarkers and targets for innovative immunotherapeutic strategies.
Amirhossein Faghih Ojaroodi, Maryam Zamani Sani, Aziza Nasirova et al.· Molecular Biology Reports· 0 citations
This review compares how EVs remodel the immune microenvironment in HT, type 2 diabetes mellitus (T2DM), and related disease contexts, with attention to donor cells, cargo, recipient pathways, biomarkers, and therapeutic implications.
Yao Ma, Wei-Na Jiang, Tong Zhou et al.· Frontiers in Immunology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.